Astera Labs, Inc. (NASDAQ:ALAB - Free Report) - Analysts at Northland Capmk issued their Q1 2026 EPS estimates for shares of Astera Labs in a report released on Tuesday, February 11th. Northland Capmk analyst G. Richard expects that the company will post earnings per share of $0.09 for the quarter. Northland Capmk currently has a "Strong-Buy" rating on the stock. The consensus estimate for Astera Labs' current full-year earnings is ($0.45) per share. Northland Capmk also issued estimates for Astera Labs' Q2 2026 earnings at $0.13 EPS, Q3 2026 earnings at $0.17 EPS and Q4 2026 earnings at $0.22 EPS.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Monday, February 10th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.26 by ($0.16). Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%.
Several other equities analysts also recently issued reports on ALAB. Barclays upped their price objective on shares of Astera Labs from $87.00 to $135.00 and gave the company an "overweight" rating in a research note on Friday, January 17th. Needham & Company LLC reaffirmed a "buy" rating and set a $140.00 price target on shares of Astera Labs in a research report on Tuesday, February 11th. Morgan Stanley cut their target price on shares of Astera Labs from $142.00 to $114.00 and set an "equal weight" rating on the stock in a report on Tuesday, January 28th. Craig Hallum increased their target price on shares of Astera Labs from $105.00 to $125.00 and gave the stock a "buy" rating in a research note on Tuesday, February 11th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Astera Labs from $60.00 to $100.00 and gave the company a "buy" rating in a research report on Tuesday, November 5th. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average target price of $115.33.
Check Out Our Latest Research Report on ALAB
Astera Labs Stock Down 0.4 %
Shares of NASDAQ:ALAB traded down $0.34 during trading on Thursday, hitting $87.85. 6,185,189 shares of the company were exchanged, compared to its average volume of 5,023,027. The firm's 50 day moving average price is $120.17 and its 200-day moving average price is $83.79. Astera Labs has a 12-month low of $36.22 and a 12-month high of $147.39.
Insider Transactions at Astera Labs
In related news, CEO Jitendra Mohan sold 171,064 shares of the stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $103.53, for a total value of $17,710,255.92. Following the completion of the sale, the chief executive officer now directly owns 628,895 shares in the company, valued at approximately $65,109,499.35. This represents a 21.38 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stefan A. Dyckerhoff sold 7,814 shares of the business's stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $107.17, for a total value of $837,426.38. Following the transaction, the director now directly owns 121,803 shares in the company, valued at $13,053,627.51. This trade represents a 6.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 639,244 shares of company stock worth $67,669,886.
Institutional Trading of Astera Labs
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Tidal Investments LLC raised its position in shares of Astera Labs by 81.8% in the 3rd quarter. Tidal Investments LLC now owns 45,298 shares of the company's stock valued at $2,373,000 after purchasing an additional 20,388 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in Astera Labs during the 3rd quarter worth $530,000. Avior Wealth Management LLC bought a new stake in shares of Astera Labs in the 3rd quarter worth about $361,000. Maverick Capital Ltd. increased its position in shares of Astera Labs by 16.0% in the 3rd quarter. Maverick Capital Ltd. now owns 1,156,230 shares of the company's stock worth $60,575,000 after purchasing an additional 159,480 shares during the last quarter. Finally, Bank of Hawaii bought a new position in shares of Astera Labs during the third quarter worth about $1,409,000. 60.47% of the stock is owned by hedge funds and other institutional investors.
Astera Labs Company Profile
(
Get Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Further Reading
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
